Applied BioCode Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Applied BioCode.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Medical Equipment earnings growth | 20.2% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 21 Mar 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2024 | 430 | -145 | -149 | -149 | 1 |
| 12/31/2023 | 395 | -164 | -211 | -205 | N/A |
| 9/30/2023 | 388 | -191 | -208 | -195 | N/A |
| 6/30/2023 | 390 | -191 | -181 | -156 | N/A |
| 3/31/2023 | 419 | -162 | 95 | 121 | N/A |
| 12/31/2022 | 390 | -185 | 124 | 146 | N/A |
| 9/30/2022 | 379 | -175 | 123 | 141 | N/A |
| 6/30/2022 | 330 | -192 | 107 | 118 | N/A |
| 3/31/2022 | 290 | -215 | -159 | -143 | N/A |
| 12/31/2021 | 320 | -165 | -168 | -152 | N/A |
| 9/30/2021 | 349 | -92 | -81 | -59 | N/A |
| 6/30/2021 | 388 | -54 | -146 | -129 | N/A |
| 3/31/2021 | 331 | -83 | -138 | -121 | N/A |
| 12/31/2020 | 299 | -103 | -175 | -147 | N/A |
| 9/30/2020 | 186 | -208 | -285 | -247 | N/A |
| 6/30/2020 | 122 | -254 | -281 | -241 | N/A |
| 3/31/2020 | 130 | -250 | -282 | -246 | N/A |
| 12/31/2019 | 105 | -280 | -338 | -314 | N/A |
| 9/30/2019 | 95 | -291 | -339 | -330 | N/A |
| 6/30/2019 | 66 | -299 | -346 | -337 | N/A |
| 3/31/2019 | 55 | -282 | -360 | -347 | N/A |
| 12/31/2018 | 37 | -268 | -305 | -287 | N/A |
| 9/30/2018 | 29 | -261 | -279 | -263 | N/A |
| 6/30/2018 | 33 | -244 | -250 | -236 | N/A |
| 3/31/2018 | 30 | -254 | -253 | -243 | N/A |
| 12/31/2017 | 27 | -263 | -256 | -250 | N/A |
| 12/31/2016 | 16 | -244 | N/A | -241 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 6598's forecast earnings growth is above the savings rate (0.8%).
Earnings vs Market: Insufficient data to determine if 6598's earnings are forecast to grow faster than the TW market
High Growth Earnings: Insufficient data to determine if 6598's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 6598's revenue is forecast to grow faster than the TW market.
High Growth Revenue: Insufficient data to determine if 6598's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 6598's Return on Equity is forecast to be high in 3 years time